Sandoz International GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope, Binocrit and Zarzio products. Sandoz offers products for oncology, central nervous system (CNS), respiratory, pain and ophthalmology. It offers products in the form of creams and gels, tablets, orodispersible films, transdermal patches, implants and inhalers. The company sells its products through a network of distributors in Germany and abroad. It has presence in Austria, Italy, Russia, the UK, France, Canada, the US, and Belgium among others. Sandoz is headquartered in Holzkirchen, Germany.

Sandoz International GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sandoz International GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sandoz International GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Sandoz Acquires Rights of Biosimilar Infliximab from Pfizer 11
Partnerships 12
Sandoz International Enters into Agreement with Biocon 12
MedinCell Enters into Agreement with Sandoz International 13
Sandoz Enters Into Co-promotion Agreement With Nipro Pharma For Somatropin BS S.C. Injection 5mg/10mg [Sandoz] 14
Licensing Agreements 15
Sandoz International Enters into Licensing Agreement with DSM Sinochem Pharma 15
Kyowa Hakko Kirin Enters into Licensing Agreement with Sandoz 16
Sandoz International GmbH - Key Competitors 17
Sandoz International GmbH - Key Employees 18
Sandoz International GmbH - Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Strategy And Business Planning 20
Apr 11, 2017: Major Novartis investment in Slovenia reinforces commitment to largest Sandoz product and business 20
Feb 08, 2017: Sandoz confirms strategic commitment to drive access to medicines in Japan, with plan to double business by 2022 21
Legal and Regulatory 22
Jun 13, 2017: US Supreme Court rules in favor of Sandoz in biosimilars case, enabling earlier access to potentially life-saving medicines 22
Jun 12, 2017: US Supreme Court clears way to early access to biosimilars 23
Product Approvals 24
Jan 27, 2017: Withdrawal of the marketing authorisation application for Zioxtenzo (pegfilgrastim) 24
Other Significant Developments 25
Aug 29, 2017: Sandoz Invests in Major Expansion of Global Headquarters in Holzkirchen, Germany 25
Jul 25, 2017: Sandoz expands partnership with World Child Cancer, to help children access treatment in four developing countries 26
Mar 20, 2017: Sandoz digital Scientific Standalone event will help drive access to medical information in field of cardiovascular therapies 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List Of Tables


Sandoz International GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sandoz International GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sandoz International GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Sandoz International GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sandoz Acquires Rights of Biosimilar Infliximab from Pfizer 11
Sandoz International Enters into Agreement with Biocon 12
MedinCell Enters into Agreement with Sandoz International 13
Sandoz Enters Into Co-promotion Agreement With Nipro Pharma For Somatropin BS S.C. Injection 5mg/10mg [Sandoz] 14
Sandoz International Enters into Licensing Agreement with DSM Sinochem Pharma 15
Kyowa Hakko Kirin Enters into Licensing Agreement with Sandoz 16
Sandoz International GmbH, Key Competitors 17
Sandoz International GmbH, Key Employees 18
Sandoz International GmbH, Subsidiaries 19

List Of Figures


Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sandoz International GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sandoz International GmbH, Medical Devices Deals, 2012 to YTD 2018 9

Sandoz International GmbH - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope,

USD 250 View Report

Sandoz Inc - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Sandoz Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Sandoz Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports

USD 350 View Report

Sandoz International GmbH - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Sandoz International GmbH (Sandoz), a subsidiary of Novartis AG develops, manufactures and commercializes generic pharmaceutical products. The company provides biosimilars, generic antibiotics, dermatology and transplantation medicines. Its biosimilars comprise Omnitrope,

USD 250 View Report

Wincor Nixdorf International GmbH Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Wincor Nixdorf International GmbH Company Profile is a detailed strategic and analytical report on Wincor Nixdorf International GmbH. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available